Gornitzky represented Shanghai GEOC Hengtong Investment Limited Partnership, a Chinese investment fund, and its affiliates in a USD 5 million Series B investment round in Vectorious Medical Technologies Ltd. in which they were the lead investors together with Broadview Ventures.
Vectorious Medical Technologies Ltd. is developing a minimally-invasive heart implant, which, together with a user-friendly external home-unit, provides easy-to-access daily medical data. The VectoriousTM system increases CHF patient quality of life by providing early, accurate physiological indication of cardiac decompensation. Patients enjoy ongoing, personalized care, physicians save lives and cut healthcare costs.
Shanghai GEOC Hengtong Investment Limited Partnership and its affiliates were represented by Timor Belan (Partner), Avi Meer, Ori Sheinkman (Labor), Oleg Omeli and Sharon Reingwirtz
